权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Molecular and functional investigation of the role of CD1 in gamma delta T cell surveillance

CD1 在 γ δ T 细胞监测中作用的分子和功能研究

基本信息

批准号：
10462661
负责人：
Erin June Adams
金额：
$ 52.47万
依托单位：
UNIVERSITY OF CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-09-22 至 2025-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10462661
关键词：
Address Adoption Anti-Inflammatory Agents Antigens Autoimmunity Binding Biochemical Biochemistry Biological Assay Biophysics CD1 Antigens Cancerous Cell Culture Techniques Cell Line Cell physiology Cells Clonal Expansion Colon Colorectal Cancer Complement Complex Crystallization Data Disease Ensure Epithelial Foundations Frequencies Generations Glycoproteins Goals Health Human Immune response Immunity Immunobiology In Vitro Individual Infection Infectious Agent Inflammatory Institutional Review Boards Investigation Laboratories Lead Ligands Link Lipids Major Histocompatibility Complex Malignant Neoplasms Mediating Memory Molecular Mus Peripheral Phenotype Physiological Play Population Protein Biochemistry Protein Engineering RNA Role Sampling Shapes Signal Transduction Specificity Stress Structure Sulfoglycosphingolipids System T-Cell Activation T-Cell Receptor T-Lymphocyte T-cell receptor repertoire Testing Tissues Transcript Tumor-Derived Umbilical Cord Blood Viral Work X-Ray Crystallography adaptive immune response antigen detection biophysical analysis cell growth colorectal cancer progression cytokine functional status human disease immunoregulation innovation insight interest pathogen peripheral blood premalignant professor receptor receptor binding recruit response structural biology success tool transcriptome sequencing tumor tumor microenvironment tumorigenesis γδ T cells

项目摘要

γδ T cells constitute an important component of the immune response against infectious agents and cancerous transformations, yet the biochemical mechanisms by which they detect antigen through their somatically recombined T cell receptor (TCR) remain unclear. Unlike αβTCRs, which are restricted to recognizing antigens in the context of Major Histocompatibility Complex (MHC) molecules, γδTCRs can recognize a diversity of ligands ranging from self MHC to intact, unprocessed, viral glycoproteins. Our recent work has established CD1 molecules as ligands for a subpopulation of human Vδ1 γδ T cells, producing robust functional, biochemical and structural evidence. We seek to extend our studies to the human gut, where γδ T cells, and in particular, Vδ1+ T cells, predominate. Our preliminary data suggests that CD1 recognition is robust and present in all individuals examined, and that there exist important functional differences between CD1 reactive γδ T cells in tumors versus healthy adjoining tissue. Thus, the long-term goal of this proposal is to fully characterize this CD1 reactive population in tumors versus healthy tissue, examining their functional effector phenotypes, TCR repertoire and immunomodulatory signals, in addition to the TCR, that shape the recruitment, activation and potential expansion of these cells in the context of a highly relevant human disease, colorectal cancer. Our first aim, “Characterization of CD1-specific γδ T cells in normal and diseased tissue.”, seeks to use classical cellular expansions complemented by direct ex vivo functional and transcript analysis to profile CD1 reactive and non- reactive T cell populations derived from tumor and adjoining healthy tissue. These data will provide insight into the signals that regulate γδ T cells within the tumor microenvironment compared to healthy tissue. Our second aim, “Elucidation of the molecular mechanisms by which γδ TCRs bind to CD1/lipid complexes.”, will focus on characterizing the interaction between the γδ TCRs expressed by these cells and CD1/lipid antigen. We will use protein biochemistry, biophysics and x-ray crystallography to elucide the molecular mechanisms by which the γδ TCR recognizes CD1/lipid. Our effort will significantly expand our understanding of the specific signals that regulate γδ T cell activity in human health and disease. Our third aim, “Determine the presence and role of ligand, co-stimulatory and/or co-receptor molecules in CD1 specific γδ T cell activation and phenotype in the colon” will characterize the ligand and immunomodulatory signals that may regulate the activity of CD1 reactive γδ T cells in the context of human colorectal cancer. We will combine RNAseq and differentiation assays using cord blood derived, naïve Vδ1 cells to test the relevance of candidate signals. This will be complemented by in vitro derived native Vδ1 T cells through the OP9/DL1 system. γδ T cells can be either pro-inflammatory or regulatory, therefore we seek to understand which role these cells play, if any, in this disease state. Together, these aims will begin to unravel the mystery of γδ T cells in human immunobiology, both at the cellular and molecular levels.

γδ T细胞是抵抗感染因子和癌症的免疫反应的重要组成部分